ET
ECM Therapeutics, Inc.
SEC filingBiotechnology · Warrendale, PA
Amount raised$35.2Msold at filing
Total offering$40M$4.8M still open
Investors in the raise190count reported to the SEC
FiledOct 10, 2025first sale May 28, 2018
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Paul F. FaganExecutive Officer, Director
Katie F. CollinsExecutive Officer, Director
Christine F. SheehyExecutive Officer
Jenna F. DzikiExecutive Officer
Stephen F. BadylakExecutive Officer, Director
George F. HusseyExecutive Officer
Lindsey F. SaldinExecutive Officer
Executive officers, directors and promoters as listed on the Form D.